Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1841

Actual shortage: 45 (2%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1782 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-08 2017-09-07 9451
SANDOZ AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-19 2021-08-03 142705
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-08-09 2021-08-23 143847
SANDOZ AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-08-09 2021-08-23 143851
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-12-20 2022-01-12 151607
SANDOZ AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2022-11-28 2023-03-28 176042
SANDOZ AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-05-08 2023-05-25 191993
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-27 2023-08-08 196662
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-07-24 2023-08-08 199806
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-10-10 2023-10-24 206684
SANDOZ ANASTROZOLE 1MG TABLET Resolved 2017-05-08 2017-05-15 9454
SANDOZ ANASTROZOLE 1MG TABLET Resolved 2021-04-12 2021-04-20 137306
SANDOZ ARIPIPRAZOLE 2MG TABLET Resolved 2021-01-12 2021-01-20 131382
SANDOZ ARIPIPRAZOLE 15MG TABLET Resolved 2021-05-31 2021-08-10 140105
SANDOZ ARIPIPRAZOLE 20MG TABLET Resolved 2021-06-14 2021-08-03 140839
SANDOZ ATOMOXETINE 10MG CAPSULE Resolved 2020-11-16 2020-12-05 128417
SANDOZ ATOMOXETINE 10MG CAPSULE Resolved 2021-03-15 2021-03-22 135617
SANDOZ ATOMOXETINE 80MG CAPSULE Resolved 2021-07-12 2021-09-29 142300
SANDOZ ATOMOXETINE 80MG CAPSULE Resolved 2022-05-24 2022-06-04 161187
SANDOZ ATOMOXETINE 40MG CAPSULE Resolved 2022-11-16 2022-11-28 174956

Showing 861 to 880 of 1841

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82